Skip to the page

Data / Drug companies / Lupin Pharmaceuticals, Inc.

Lupin Pharmaceuticals, Inc.: 331 products in the FDA NDC directory, labeler code 68180

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Lupin Pharmaceuticals, Inc. (labeler code 68180) lists 331 products in the FDA National Drug Code Directory, covering 111 finished drugs by generic name. By type: 330 prescription drugs, 1 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on May 4, 2026.

The request: Watch Lupin Pharmaceuticals, Inc. (FDA labeler code 68180): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
68180
Products in commercial distribution
331
Packages
413
Finished drugs by generic name
111
Prescription products
330
Over the counter products
1
Controlled substance products
Schedule III 2, Schedule IV 13
Flagged as original packager
308 of 308 products that carry the flag
Started marketing in the last 12 months
1
Earliest marketing start
December 1, 2005
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)32798.8%
Authorized generics (NDA)41.2%

Products by type

TypeProductsShare
Prescription drugs33099.7%
Over the counter drugs10.3%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Levothyroxine sodium1244
Lisinopril1040
Amlodipine besylate and benazepril hydrochloride1012
Losartan potassium943
Levetiracetam687
Memantine hydrochloride636
Sertraline hydrochloride655
Tramadol hydrochloride644
Quetiapine fumarate633
Norethindrone acetate and ethinyl estradiol610
Levonorgestrel and ethinyl estradiol619
Fenofibrate656
Valsartan and hydrochlorothiazide521
Cefprozil57
Desoximetasone514
Divalproex sodium548
Simvastatin532
Quetiapine530
Lurasidone hydrochloride528
Amlodipine, valsartan and hydrochlorothiazide52
Eslicarbazepine acetate410
Imipramine pamoate43
Celecoxib463
Atorvastatin calcium459
Cephalexin436
Meloxicam454
Pravastatin sodium439
Ramipril419
Quinapril410
Oseltamivir phosphate437
Minocycline hydrochloride429
Amlodipine and valsartan410
Duloxetine436
Metformin hydrochloride479
Cefadroxil315
Lisinopril and hydrochlorothiazide321
Trandolapril35
Paroxetine333
Rufinamide312
Lanthanum carbonate37
Norgestimate and ethinyl estradiol320
Norethindrone and ethinyl estradiol312
Droxidopa315
Imipramine hydrochloride314
Eszopiclone329
Cefixime37
Clomipramine hydrochloride capsules31
Cefdinir325
Azithromycin341
Fluoxetine hydrochloride344
Losartan potassium and hydrochlorothiazide331
Levofloxacin342
Amlodipine besylate349
Lovastatin322
Desvenlafaxine succinate312
Doxycycline363
Telmisartan and hydrochlorothiazide39
Mirabegron210
Telmisartan and amlodipine24
Ethambutol hydrochloride27
Moxifloxacin219
Doxyclycline hyclate21
Drospirenone and ethinyl estradiol216
Clobetasol propionate240
Zolpidem tartrate238
Norethindrone217
Nabumetone230
Bupropion hydrochloride267
Irbesartan227
Bromfenac28
Darunavir214
Rifampin213
Testosterone222
Fenofibric acid27
Clobazam218
Ranolazine230
Silodosin215
Levonorgestrel131
Hydrocortisone butyrate16
Famotidine1138
Niacin113
Sildenafil153
Abacavir , lamivudine and zidovudine11
Diclofenac sodium1109
Betamethasone dipropionate127
Emtricitabine and tenofovir disoproxil fumarate128
Abacavir and lamivudine16
Nystatin and triamcinolone acetonide118
Rivaroxaban124
Tobramycin141
Quinine sulfate14
Potassium chloride184
Norgestrel and ethinyl estradiol17
Tadalafil154
Budesonide inhalation14
Escitslopram11
Bosentan17
Lamivudine114
Hydrocortisone valerate13
Albuterol sulfate146

Dosage forms

Dosage formProductsShare
Tablet10832.6%
Tablet, film coated5316%
Capsule4914.8%
Tablet, extended release247.3%
Kit236.9%
Tablet, film coated, extended release154.5%
Powder, for suspension123.6%
Capsule, delayed release61.8%
Solution51.5%
Cream51.5%
Capsule, extended release41.2%
Tablet, chewable30.9%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Cefprozil68180-273Powder, for suspensionGeneric drugs (ANDA)May 4, 2026
Bosentan68180-340Tablet, for suspensionGeneric drugs (ANDA)August 18, 2025
Blisovi fe 1.5/3068180-869KitGeneric drugs (ANDA)August 13, 2025
Sertraline Hydrochloride68180-992Tablet, film coatedGeneric drugs (ANDA)August 6, 2025
Sertraline Hydrochloride68180-986Tablet, film coatedGeneric drugs (ANDA)August 6, 2025
Sertraline Hydrochloride68180-978Tablet, film coatedGeneric drugs (ANDA)July 20, 2025
Eslicarbazepine Acetate68180-293TabletGeneric drugs (ANDA)May 6, 2025
Eslicarbazepine Acetate68180-292TabletGeneric drugs (ANDA)May 6, 2025
Eslicarbazepine Acetate68180-291TabletGeneric drugs (ANDA)May 6, 2025
Eslicarbazepine Acetate68180-290TabletGeneric drugs (ANDA)May 6, 2025
Rivaroxaban68180-709Tablet, film coatedGeneric drugs (ANDA)March 6, 2025
Enskyce68180-739KitGeneric drugs (ANDA)December 10, 2024
Mirabegron68180-152Tablet, film coated, extended releaseGeneric drugs (ANDA)September 3, 2024
Amlodipine Besylate68180-455TabletGeneric drugs (ANDA)June 12, 2024
Mirabegron68180-151Tablet, film coated, extended releaseGeneric drugs (ANDA)April 19, 2024
Amlodipine Besylate68180-233TabletGeneric drugs (ANDA)April 11, 2024
Diclofenac Sodium68180-537SolutionGeneric drugs (ANDA)February 19, 2024
Bromfenac68180-434Solution/ dropsGeneric drugs (ANDA)February 12, 2024
Bromfenac68180-436SolutionGeneric drugs (ANDA)February 2, 2024
Bromfenac sodium68180-433Solution/ dropsGeneric drugs (ANDA)January 8, 2024
Turqoz68180-895KitGeneric drugs (ANDA)November 29, 2023
Tiotropium Bromide68180-964CapsuleGeneric drugs (ANDA)August 16, 2023
Rufinamide68180-797SuspensionGeneric drugs (ANDA)June 22, 2023
Darunavir68180-346Tablet, film coatedGeneric drugs (ANDA)June 1, 2023
Darunavir68180-345Tablet, film coatedGeneric drugs (ANDA)June 1, 2023

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.